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Studies in cystic fibrosis patients and mice overexpressing
the epithelial Na channel -subunit (ENaC-Tg) suggest
that raised airway Na transport and airway surface liquid
(ASL) depletion are central to the pathogenesis of cystic
fibrosis lung disease. However, patients or mice with Liddle
gain-of-function ENaC mutations exhibit hypertension but
no lung disease. To investigate this apparent paradox, we
compared the airway phenotype (nasal versus tracheal) of
Liddle with CFTR-null, ENaC-Tg, and double mutant mice.
In mouse nasal epithelium, the region that functionally mim-
ics human airways, high levels of CFTR expression inhibited
Liddle epithelial Nat channel (ENaC) hyperfunction. Con-
versely, in mouse trachea, low levels of CFTR failed to sup-
press Liddle ENaC hyperfunction. Indeed, Na transport
measured in Ussing chambers (“flooded” conditions) was
raised in both Liddle and ENaC-Tg mice. Because enhanced
Na transport did not correlate with lung disease in these
mutant mice, measurements in tracheal cultures under phys-
iologic “thin film” conditions and in vivo were performed.
Regulation of ASL volume and ENaC-mediated Na absorp-
tion were intact in Liddle but defective in ENaC-Tg mice.
We conclude that the capacity to regulate Na transport and
ASL volume, not absolute Na transport rates in Ussing
chambers, is the key physiologic function protecting airways
from dehydration-induced lung disease.
The amiloride-sensitive epithelial Na channel (ENaC)3 is a
heteromultimeric protein composed of three subunits (, ,
and ). ENaC is limiting for the absorption of salt and water
from airway and other epithelia, including renal and colonic
epithelia (1–3). Increased ENaC-mediated airway Na absorp-
tion is a hallmark of cystic fibrosis (CF) (4, 5), a genetic form of
chronic obstructive lung disease caused by mutations in the
cystic fibrosis transmembrane conductance regulator (CFTR)
gene (6, 7). Numerous studies have indicated that CFTR func-
tionsasaClchannelregulatedbycAMP-dependentphosphor-
ylation and as a regulator of ENaC in airway epithelia (1, 8–11).
Previous in vitro studies indicated that the increased Na
absorption in CF airways is caused by increased apical mem-
brane ENaC activity, reflecting deficient inhibition by mutant
CFTR, and that Na hyperabsorption is associated with airway
surface liquid (ASL) volume depletion and impaired mucus
clearance (12–14).
The concept that increased airway Na absorption and ASL
volume depletion play a critical role in the in vivo pathogenesis
of CF lung disease, however, remains controversial. For exam-
ple, a recent hypothesis proposes that an acidic ASL pH, due to
deficient HCO3 secretion by mutant CFTR, rather than defi-
cient ASL volume regulation, produces increased mucus vis-
cosity, reduced mucus clearance, and CF airway disease (15).
The role of ASL volume depletion in CF pathogenesis was but-
tressed by a recently developed mouse model with airway-spe-
cific overexpression of ENaC under the control of the Clara
cell secretory protein promoter (16). In this mouse model,
selective airway overexpression of ENaC was sufficient to
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reduce mucus clearance, and produce a spontaneous lung dis-
ease that shared key features with CF and other chronic
obstructive pulmonary diseases, including substantial pulmo-
nary mortality, airway mucus obstruction, goblet cell metapla-
sia, chronic airway inflammation, and slowed clearance of bac-
terial pathogens (16, 17). Taken together, the results from these
in vitro and in vivo studies suggest that increased airway Na
absorption, produced either by deficient CFTR-mediated inhi-
bition of ENaC in human CF airways or by transgenic overex-
pression of wild-type ENaC in murine airways, causes ASL
volume depletion, which initiates a series of pathogenetic steps
that cause chronic obstructive lung disease.
Importantly, a third mechanism exists that can increase epi-
thelial Na absorption. Gain-of-function mutations have been
identified in the genes encoding - and ENaC (Scnn1b and
Scnn1g) that cause a constitutive increase in Na transport in
the distal nephron of the kidney, resulting in an autosomal
dominant form of salt-sensitive hypertension known as Liddle
syndrome or pseudoaldosteronism (18–20). The molecular
pathogenesis of Liddle syndrome has been studied in detail, and
it has been demonstrated that the disease is caused by muta-
tions that delete a proline-rich (PY)motif in the C termini of -
and ENaC that is critical for binding of the ubiquitin-protein
ligase Nedd4-2. Nedd4-2 binding leads to ubiquitination and
retrieval of ENaC from the plasma membrane. In Liddle syn-
drome, abrogation of the ENaC/Nedd4-2 interaction results in
an increased number of ENaC channels in the plasma mem-
brane, producing increased renal sodium absorption and salt
sensitive hypertension (21–23). Because Nedd4-2 binding to
ENaC is under control of Sgk1 (serum- and glucocorticoid-
induced kinase 1), both Nedd4-2 and Sgk1 are key regulators of
ENaC in the kidney (24–26).
Little is known about the pulmonary phenotype in Liddle
syndrome, but Liddle patients do not develop overt lung disease
(27, 28). In a mouse model that carries the classical Liddle
mutation (i.e. a premature stop codon in the Scnn1b gene cor-
responding to the R556X mutation in Liddle patients), it has
been shown that this gain-of-function mutation causes in-
creased Na absorption in the distal nephron of the kidney, the
colon, and the alveolar air spaces of the lung, but the phenotype
of the conducting airways has not been studied (29–33). The
aim of the present study was to elucidate the effects of this
endogenously expressed gain-of-function mutation in ENaC
on airwayNa and volume transport and correlate each param-
eter with phenotypes in the upper (nasal) and lower airways.
Studies of the lower airways included (i) Ussing chamber mea-
surements of transepithelial Na transport under “flooded”
conditions in native tissues, (ii) confocal ASL volumemeasure-
ments under physiologic “thin film” conditions in cultured
preparations, and (iii) a morphologic search for evidence of
abnormal regulation of Na transport in vivo.
EXPERIMENTAL PROCEDURES
Experimental Animals—All animal studies were approved
by the animal care and use committee of the University of
North Carolina at Chapel Hill and the Regierungspra¨sidium
Karlsruhe, Germany. The generation and genotyping of Liddle
mice, ENaC-Tg mice, and CF (Cftr/) mice has been
described previously (16, 29, 34, 35). Liddlemicewere originally
generated on a mixed genetic background (129Ola  C57BL/
6J) and were backcrossed for 5 generations to the C57BL/6J
background. ENaC-Tg mice (line 6608) were generated on a
mixed genetic background (C3H/HeN C57BL/6N) and were
backcrossed (N10) to the C57BL/6J background. CF mice were
on amixed genetic background (BALB/c, C57BL/6,DBA/2, and
129/SvEv). Mice heterozygous for the Liddle mutation (L/)
were interbred, and homozygous Liddle mice (L/L) and wild-
type (WT) littermates were studied at the age of 12–16 weeks.
CFmicewere intercrossedwith Liddlemice and doublemutant
CF mice homozygous for the Liddle mutation (CF-Liddle),
andCF, L/L, andWT littermate controlswere studied at the age
of 16–54 weeks. ENaC-Tg mice and WT littermates were
6–8 weeks of age. Airway epithelial necrosis was studied in
3-day-old mice of respective genotypes. Mice were housed
in specific pathogen-free animal facilities. CF mice received
Colyte instead of drinking water to prevent intestinal obstruc-
tion. All other animals had free access to regular chow and
water.
In Vivo Potential Difference (PD)Measurements—For in vivo
studies of transepithelial PD, mice were anesthetized via intra-
peritoneal injection of avertin (0.4 g/kg tribromoethanol, 0.4
ml/kg amyl alcohol), and the body temperature was continually
monitored with a rectal thermocouple (Physitemp) and main-
tained at 37 °C with a heat lamp. Nasal and rectal PD measure-
ments were performed, and the basal PD and the amiloride-
sensitive PD were determined as described previously (29, 36).
Ussing Chamber Measurements—Mice were killed with 100%
CO2, nasal and tracheal tissues were removed and mounted on
modified Ussing chambers, and bioelectric measurements were
taken as described previously (13, 16, 37). In most studies, we
used recirculating chambers tomeasure basal short circuit cur-
rent (Isc) and the sequential effects of amiloride (100mol/liter;
luminal), forskolin (10 mol/liter; luminal), and UTP (100
mol/liter; luminal). Studies on protease regulation of ENaC-
mediated Na transport and amiloride dose-response studies
were performed in continuously perfused chambers under
open circuit conditions, and the equivalent short circuit current
(Ieq) was calculated from the PD and the transepithelial resis-
tance (Rte) according to Ohm’s law (i.e. Ieq  PD/Rte) as
described previously (13). Dose-response curves were obtained
by measuring the change in Ieq induced by exposing tissues to
increasing concentrations of amiloride (109 to 103mol/liter)
and plotted as remaining amiloride-sensitive Ieq (Iamil) normal-
ized to the maximal amiloride-sensitive Ieq (Imax). IC50 values
were determined by fitting dose-response data to theHill equa-
tion with the Hill coefficient constrained to 1.0 as follows,
Iamil Imax 1 1/1 IC50/A (Eq. 1)
where A is the apical bath amiloride concentration. Addition-
ally, data were fitted with a two-component Hill model,
Iamil Imax 1 Ifrct/1 IC50HA/A 1 Ifrct/1 IC50LA/A
(Eq. 2)
where subscripts HA and LA denote the high affinity and low
affinity IC50, respectively, and Ifrct is the fractional HA ENaC
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population. The LA ENaC population  1  Ifrct. The models
that best fit the dose-response data were judged based on com-
parison of S.E. using an F-test distribution,
Fcalck1,n k2 S1 S2 n1 k2/S2 k2 (Eq. 3)
where S is the residual sum of squares, n is the number of data
points, k is the number of free parameters, and subscripts 1 and
2 depict parameters of the one- and two-component Hill
model, respectively (38). For studies of ENaC regulation by
extracellular serine proteases, tissues were equilibrated in the
presence of the protease inhibitor aprotinin (100 g/ml, 3.8
trypsin inhibitory units/mg; Sigma) added to the apical bath,
and the effect of amiloride (100 mol/liter; luminal) was either
measured in the presence of aprotinin alone or after adding a
2-fold excess of trypsin (550 g/ml, 14,000 N-benzoyl-L-
arginine ethyl ester units/mg; Sigma) on the basis of activity (1
trypsin unit 9000 N-benzoyl-L-arginine ethyl ester units).
Real-time RT-PCR—Mice were killed with 100% CO2 and
nasal and tracheal tissues were immediately removed and
stored in RNAlater (Ambion, Austin, TX). Total RNA was iso-
lated using the RNeasy kit (Qiagen Inc., Valencia, CA) and
reverse transcribed into cDNA using Superscript II (Invitro-
gen). Quantification of ENaC, ENaC, ENaC, CFTR,
Nedd4-2, and Sgk1 mRNA expression was performed using
SYBRGreendetection in a LightCycler PCRmachine according
to themanufacturer’s instructions (RocheApplied Science) and
the following custom made primers (MWG Biotech, High
Point, NC): ENaC, 5	-CGG AGT TGC TAA ACT CAA
CATC-3	 (sense) and 5	-TGG AGA CCA GTA CCG GCT-3	
(antisense); ENaC, 5	-TAA TGG AGG CAG TCC TGG-3	
(sense) and 5	- GTT GGC AGA AGG AAG TGT CT-3	 (anti-
sense); ENaC, 5	-CAG GCG CAT AGC AGA GGT A-3	
(sense) and 5	-ACC TGG CCA AGC TCT TGA TA-3	 (anti-
sense); CFTR, 5	-ACCACAGGCATAATCATGG-3	 (sense)
and 5	-AGC AGA ATG AAA CTC TTC CAC-3	 (antisense);
Nedd4-2, 5	-GAT ACC CTT TCC AAT CCA CA-3	 (sense)
and 5	-AGG ACG TCA GGT CTC TTT ACA-3	 (antisense);
Sgk1, 5	-ACA ACA TCT ACC TTC TGT GGC-3	 (sense) and
5	- CATAAAGTCATCCTTGGCAC-3	 (antisense). Relative
-fold changes in target gene expression were calculated from
the efficiency of the PCR and the crossing point deviation
between samples from experimental groups and determined by
normalization to expression of the reference gene 18 S or -ac-
tin, as described previously (17).
Histology and AirwayMorphometry—Adult mice were killed
with 100% CO2, and neonatal mice were killed by decapitation.
Lungs were removed through a median sternotomy, immer-
sion-fixed in 4% buffered formalin, and embedded in paraffin.
Sections were cut at 5 m and stained with hematoxylin and
eosin (H&E) or Alcian blue periodic acid-Schiff as described
previously (16). Necrotic airway epithelial cells were identified
by morphologic criteria (i.e. cell swelling with cytoplasmic vac-
uolization), and numeric cell densities were quantitated by
counting epithelial cells/mm of the basement membrane as
described previously (17).
Primary Tracheal Epithelial Cultures—Mice were eutha-
nized with 100% CO2, the tracheas were removed, and epithe-
lial cells were isolated and cultured on membranes (T-Col,
Costar, Cambridge, MA) under air-liquid interface conditions
and studied after reaching confluence (10 days), and some cul-
tures were subjected to Ussing chamber studies to determine
amiloride-sensitive Na transport, as described previously
(16).
ASL Height Measurements—Primary tracheal epithelial cul-
tures were washed, and 20 l of PBS containing 0.2% (v/v)
Texas Red-dextran (10 kDa; Molecular Probes) was added to
the lumen to visualize theASL layer. Adding this volume of PBS
results in an initial ASL height of 20–30 m, as described
previously (39). Images of the Texas Red-labeled ASL were
acquired by laser-scanning confocal microscopy (LSM 510,
Carl Zeiss, Jena, Germany) using the appropriate filters for
Texas Red (540 nm excitation/630 nm emission). To avoid
evaporation of the thin ASL layer, 100 l of immiscible per-
fluorocarbon (Fluorinert-77, 3M Corp.) was added to the
airway surface following the addition of the labeling dye (39).
The height of the ASL was measured by averaging the heights
obtained from xz scans of five predetermined points on the
culture. In the experiments described here, ASL height was
measured 15 min following the addition of the Texas Red-dex-
tran and at designated time points over a period of 24 h in
primary tracheal epithelial cultures from Liddle mice,
ENaC-Tg mice, and their respective WT littermates.
Statistics—All data were analyzed with SigmaStat version 3.1
(Systat Software, Erkrath, Germany) and are reported as
mean 
 S.E. Statistical analyses were performed using Stu-
dent’s t test, the Mann-Whitney rank sum test, one-way analy-
sis of variance, andKruskal-Wallis analysis of variance on ranks
as appropriate, and p 0.05 was accepted to indicate statistical
significance.
RESULTS
The LiddleMutation Does Not Cause Gain of Na Transport
Function in Nasal Epithelia—To study the effect of the Liddle
mutation on airway Na transport, we first performed in vivo
measurements of nasal PD in Liddle mice and WT littermate
controls. Basal and amiloride-sensitive nasal PD values in WT
mice were similar to those in previous studies (36), and neither
value was different in Liddle mice (Fig. 1A). In contrast, rectal
PD measurements demonstrated that both basal and amilo-
ride-sensitive rectal PD were significantly increased in Liddle
mice compared with WT controls (supplemental Fig. 1), as
described previously (29). The absence of increased Na
absorption in nasal epithelia of Liddlemicewas confirmed by in
vitro measurements of basal and amiloride-sensitive transepi-
thelial short circuit current (Isc) across freshly excised nasal
epithelia (Fig. 1B). Furthermore, following amiloride pretreat-
ment, cAMP-stimulated Cl secretion was the same in Liddle
and WT tissues (supplemental Fig. 2A). Ca2-activated (UTP)
Cl secretion was absent in both genotypes (supplemental
Fig. 2A), as described previously for WT mice (36).
The Liddle Mutation Does Cause Gain of Na Transport
Function in Tracheal Epithelia—Because previous studies from
CFmice suggested that the regulation of ENaC function differs
in mouse upper and lower airways (36, 37, 40), we also studied
the effect of the Liddle mutation on ion transport in freshly
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excised tracheal epithelia. The magnitude of amiloride-sensi-
tive Na absorption in WT mice was substantially smaller in
tracheal than nasal epithelia (Fig. 1, B and C). However, basal
and amiloride-sensitive Isc were significantly increased in tra-
cheal tissues fromLiddle comparedwithWT tracheas (Fig. 1C).
Following amiloride pretreatment, themagnitude of Cl secre-
tion stimulated by either cAMP or Ca2 agonists did not differ
between Liddle andWTmice (supplemental Fig. 2B). This indi-
cates that agonist-mediated Cl secretory capacity was not
altered by the Liddle mutation under conditions of amiloride
block.
Expression of ENaC Subunits and ENaC Regulators in Upper
and Lower Airway Epithelia—To identify mechanisms regulat-
ing Na transport rates in nasal versus tracheal epithelia inWT
and Liddlemice, wemeasured transcript levels of individual -,
-, and ENaC subunits and several known ENaC regulators,
including CFTR, the ubiquitin protein ligase Nedd4-2, and the
serum and glucocorticoid-activated kinase Sgk1 in freshly
excised tissues from both genotypes (10, 11, 23, 24, 26).
To investigate the differences in Na transport rates in WT
versus Liddle mouse airways, transcript levels in Liddle mice
were normalized to levels in WT mice. Expression of the
mutated ENaC was significantly reduced in both Liddle nasal
and tracheal tissues, as described previously for kidney and
colon, probably reflecting RNA instability caused by the resid-
ual loxP site in the targeting construct (29) (Fig. 2). However,
expression levels of ENaC, ENaC, Nedd4-2, Sgk1, and CFTR
were not different in Liddle mice compared with WT controls
in either nasal or tracheal epithelia (Fig. 2, A and B).
To determine the differences in nasal versus tracheal Na
transport, we normalized transcript levels in nasal to tracheal
epithelia of WTmice. Consistent with higher Na transport in
nasal versus tracheal epithelia (Fig. 1, B and C), these studies
revealed that expression levels of -, -, and ENaC were all
significantly increased in the nose compared with the trachea
(Fig. 2C). Although Nedd4-2 and Sgk1 were also relatively
increased in nasal epithelia, the highest -fold change in expres-
sion was for CFTRmRNA, which was20-fold higher in nasal
compared with tracheal epithelia (Fig. 2C).
CFTR Inhibits Gain of ENaC Function in Nasal Epithelia
from Liddle Mice—To more directly investigate the role of
CFTR in regulation of the Liddle mutated ENaC in native air-
way tissues, we generated double mutant mice that were defi-
cient inCFTR (CF) andhomozygous for either the Liddlemuta-
FIGURE 2. Expression of ENaC subunits and ENaC regulators in nasal and
tracheal epithelia. A–C, transcript levels of ENaC, ENaC, ENaC, CFTR,
Nedd4-2, and Sgk1 in freshly excised nasal and tracheal tissues from L/L and
WTmice. A and B, comparison of transcript expression levels in nasal (A) and
tracheal (B) tissues from L/L versus WT mice. Data are expressed as -fold
changes fromWT.n5–6mice/group; *,p0.05; **,p0.01.C, comparison
of expression levels in tracheal tissues (open bars) versus nasal tissues (closed
bars) fromWTmice.Data are expressedas -fold changes from tracheal tissues.
n 5–6 mice/group; **, p 0.01; ***, p 0.001. Error bars, S.E.
FIGURE 1. Effect of the Liddle mutation on airway Na absorption. A–C, in vivo measurements of basal and amiloride-sensitive nasal PD (A) and ex vivo
measurements of basal and amiloride-sensitive Isc in nasal tissues (B) and tracheal tissues (C) from Liddle (L/L) andWTmice. n 5–17mice/group. *, p 0.05;
**, p 0.001 compared with WT. Error bars, S.E.
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tion (CF-Liddle) or the wild-type Scnn1b allele and performed
in vivo nasal PD measurements and transepithelial Ussing
chamber measurements on nasal and tracheal epithelia (Fig. 3,
A–C). In vivo nasal PD measurements demonstrated that basal
and amiloride-sensitive PDwere significantly increased in dou-
ble mutant CF-Liddle, in a stepwise relationship, compared
with (i) the raised PDs of CF littermates, (ii) “normal” PDs of
Liddlemicewith awild-typeCFTR genotype, and (iii)WTmice
(Fig. 3A). Further, in vitro measurements of transepithelial Isc
revealed similar stepwise relationships for basal and amiloride-
sensitive Isc in nasal tissues from CF-Liddle compared with CF
mice, Liddlemice expressingwild-typeCFTR, orWTmice (Fig.
3B). Conversely, in tracheal tissues, the lack of CFTR had no
effect on basal and amiloride-sensitive Isc in CF-Liddle com-
pared with Liddle mice (Fig. 3C). Similar to Liddle mice
expressingwild-typeCFTR (supplemental Fig. 2), Cl secretory
capacity following activation with forskolin or UTP was not
different in amiloride-pretreated nasal or tracheal tissues from
CF-Liddle mice compared with CF controls (supplemental
Fig. 3). Taken together, these data indicate that wild-typeCFTR
inhibits the Liddle ENaC gain of Na transport function when
both proteins are co-expressed in the nasal epithelium. Con-
versely, these data are consistent with the hypothesis that low
levels of tracheal CFTR expression were insufficient to inhibit
the Liddle ENaC gain of function in the trachea.
Morphologic Evaluation of Lungs from Liddle Mice—Liddle
mice exhibited normal survival and no spontaneous airway dis-
ease phenotype, including absence of histological evidence of
mucus obstruction, goblet cell metaplasia, or airway inflamma-
tion, compared with WT controls (Fig. 4). Similar to the find-
ings in Liddlemice, airways pathologywas also absent in double
mutant CF-Liddle mice (Fig. 4). In contrast, ENaC-Tg mice
with a comparable level of increased trachealNa absorption at
4–8 weeks after birth exhibit airway mucus plugging, airway
epithelial remodeling with goblet cell hyperplasia, neutrophilic
inflammation, and emphysema (16, 17).
ASL Volume Regulation by WT, Liddle, and ENaC-Tg Cul-
tured Airway Epithelia—Airway epithelial volume homeostasis
requires the capacity to reciprocally regulate Na absorption
and Cl secretion (39, 41). Our previous studies demonstrated
that airway Na hyperabsorption induced by tissue-specific
FIGURE 3. Effect of the Liddle mutation on airway Na absorption in
CFTR-deficient mice. A–C, in vivo measurements of basal and amiloride-
sensitive nasal PD (A) and ex vivo measurements of basal and amiloride-
sensitive Isc in nasal tissues (B) and tracheal tissues (C) from WT mice, L/L
mice, single mutant CFTR-deficient (CF) mice, and double mutant CFTR-
deficient Liddle (CF  L/L) mice. A, nasal PD measurements. n  8–12
mice/group. *, p  0.001 compared with WT and L/L mice; †, p  0.001
compared with WT, L/L, and CF mice. B, nasal Isc measurements. n  5–7
mice/group. *, p  0.05 compared with WT and L/L mice; †, p  0.02
compared with L/L mice; ‡, p  0.01 compared with WT and L/L mice; §,
p  0.05 compared with CF mice. C, tracheal Isc measurements. n  6–9
mice/group. *, p  0.05 compared with WT mice; †, p  0.01 compared
with L/L mice. ‡, p	 0.02 compared with CF mice; §, p 0.001 compared
with WT and CF mice. Error bars, S.E.
FIGURE 4. Effect of the Liddlemutationonairwaymorphology. Lunghistology fromadultWTmice, L/Lmice, CFmice, doublemutant CFTR-deficient Liddle
(CF L/L)mice, andENaC-Tgmice stainedwithH&EandAlcianblueperiodic acid-Schiff (AB-PAS). Scale bars, 100m.Results shownare representative forn
6–14 mice/group.
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overexpression of ENaC causes ASL volume depletion and
deficient mucus clearance in vivo, indicating that overexpres-
sion of ENaC produced an unregulated ENaC channel that
produced lung disease via airway surface dehydration (16, 17).
To test the hypothesis that the absence of pulmonary pathology
in Liddle mice reflected “normal” regulation of Liddle ENaC in
vivo in the lung, we generated the primary epithelial culture
preparations required for studies of ASL volume regulation
under physiologic thin film conditions. Similar to freshly
excised tracheal tissues, Ussing chamber studies under flooded
conditions demonstrated that amiloride-sensitive Na trans-
port was significantly increased in tracheal cultures fromLiddle
mice (Isc 21.8
 5.4 A/cm2, n 12 forWT; Isc 60.7

15.3 A/cm2, n 12 for Liddle; p 0.05) and ENaC-Tgmice
(Isc  13.9 
 3.4 A/cm2, n  6 for WT; Isc  45.9 
 7.9
A/cm2, n  5 for ENaC-Tg; p  0.01) compared with WT
controls.
For ASLmeasurements under thin film conditions, a small
volume of liquid (20 l) was added to the luminal compart-
ment of confluent tracheal cultures grown at an air-liquid
interface, and ASL height was monitored sequentially over a
period of 24 h by confocal laser-scanning microscopy (39,
41). In WT cultures, the added liquid was largely absorbed
within a period of4 h. Subsequently, ASL height was main-
tained at 6 m, corresponding to the height of extended
cilia in mice (Fig. 5). This volume homeostatic response
probably reflected the inhibition of Na transport and accel-
eration of Cl secretion reported duringASL volumehomeo-
stasis in cultured normal human airway epithelia (39, 41).
In cultures from ENaC-Tg mice, the initial rate of liquid ab-
sorption was significantly increased
compared with WT controls, consis-
tent with increased Na absorp-
tion. Importantly, these cultures
failed to slow absorption when
ASL approached the height of out-
stretched cilia and removed all
of the available liquid from airway
surfaces (Fig. 5A). This pattern of
ASL volume hyperabsorption re-
flects increased and unregulated
airway Na absorption, a pattern
also observed in human CF airway
cultures (14, 39). In tracheal cul-
tures from Liddle mice, similar to
ENaC-Tgmice, initial ASL volume
absorptionwas also accelerated, and
ASL was almost entirely removed
from culture surfaces within 2 h fol-
lowing the volume challenge. How-
ever, in contrast to ENaC-Tg cul-
tures, where ASL remained
depleted, Liddle epithelia added
ASL to their surfaces during the
7–24 h phase and regulated ASL
height to levels similar to WT con-
trols (i.e.6 m) (Fig. 5B).
The Liddle Mutation Does Not
Cause Airway Epithelial Cell Necrosis—The confocal ASL data
suggest that Liddle ENaC is regulated in the lower airways at
physiologic ASL volumes, whereas ENaC-Tg channels are
not. To search for in vivo correlates of Na channel regulation,
we quantitated the number of Clara cells undergoing hydropic
degeneration. Hydropic degeneration has been reported in
neurons in Caenorhabditis elegans that express gain-of-
function mutations in a channel homologous to ENaC, the
degenerin channel (42, 43). The gain-of-function mutations
in the degenerin channel appear to lock the channel into an
unregulated open mode with an open probability (Po)
approaching 1.0. Necrotic (hydropic degenerated) cells were
detected in airway epithelia from neonatal ENaC-Tg mice
(Fig. 6, A and B) but not in adult ENaC-Tg mice (data not
shown), as reported previously (17). In contrast to ENaC-Tg
mice, we detected no necrotic cells in airways of Liddle mice at
any time period (Fig. 6, A and B).
ENaC Sensitivity to Amiloride in Airways of WT, Liddle, and
ENaC-Tg Mice—The presence of necrotic cells in the airway
epitheliumofENaC-Tgmice, but not Liddlemice, suggested a
defect in ENaC regulation in ENaC-Tg but not Liddle murine
airway epithelia. We therefore searched for a mechanism that
may predict abnormal regulation ofENaC-Tg channels. In the
ENaC-Tg mice, ENaC is expressed 20–100-fold greater
than the endogenous ENaC, raising the possibility that 
ENaC channels may be formed in vivo. Compared with 
ENaC channels, heterologous expression of- andENaC sub-
units inXenopus oocytes produces reducedwhole cell Na cur-
rents, probably due to inefficient processing of  ENaC (1).
However,  ENaC channels that are inserted into the plasma
FIGURE 5.ASL volume regulation in airway epithelia fromLiddlemice andENaC-Tgmice. A–C, Confocal
images (A) and summary of measurements of ASL height (B and C) at 0, 2, 4, 8, and 24 h after the mucosal
addition of 20l of PBS containing Texas Red dextran to primary tracheal epithelial cultures fromENaC-Tg (A
and B), L/Lmice (A and C), and the respectiveWT littermates. Scale bars, 7m. n 3–6mice/group. *, p 0.05
compared with WT. **, p 0.01 compared with WT. Error bars, S.E.
ENaC and ASL Regulation
26950 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 35•AUGUST 27, 2010
 at SM
AC Consortium
 - Lausanne, on Novem
ber 10, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
membrane have a resting open probability of 1.0, compared
with 0.5 for heterologously expressed  ENaC channels
(44). This finding suggests that  ENaC channels are abnor-
mally regulated in oocytes so that they are maximally activated
under resting conditions. Another important characteristic of
the ENaC channel is that it is less sensitive to amiloride than
the  ENaC channel in oocytes, with the amiloride IC50
shifted about 1 log to the right of  ENaC (1, 11, 45). In
contrast to alveolar epithelial cells (46), it was not possible to
obtain cell-attached membrane patches from the apical mem-
brane of well differentiated mouse airway epithelial cells to
measure Po directly. We therefore tested the hypothesis that
ENaC-Tg may express abnormally regulated  ENaC chan-
nels by characterizing the amiloride sensitivity of freshly
excised tracheas from ENaC-Tg, Liddle, and WT mice.
Analysis of amiloride dose-response curves using a single
component Hill model demonstrated that the amiloride IC50
for Liddle tracheas was slightly shifted (1.5-fold) to the right
of WT littermate controls. However, in ENaC-Tg tracheas,
the shift in IC50 to the right of WT tissues was significantly
larger (4.8-fold), suggesting that the sensitivity to amiloride
was significantly reduced in ENaC-Tg compared with Liddle
tracheas (Fig. 6,C–E). Modeling of dose-response curves with a
single component versus a two-component Hill model demon-
strated that the amiloride dose-response curve in ENaC-Tg
tracheas was described significantly better by the two-compo-
nent model compared with the single component model (p 
0.025). This finding is consistent with two channel populations
(i.e. a high affinity channel population (IC50 0.6
 0.1 mol/
liter) and a second population of low affinity channels (IC50
30.9 
 10.7 mol/liter)), which constituted 35% of the total
ENaC channel population (Table 1). In contrast, IC50 values
determined by the single component versus the two-compo-
nent Hill model did not differ statistically in WT and Liddle
tracheae (Table 1), consistent with expression of a single high
affinity ENaC channel population in WT and Liddle mice.
FIGURE 6. Regulation of ENaC in airway epithelia is abnormal in ENaC-Tg mice but preserved in Liddle mice. A, airway histology from neonatal
(3-day-old)ENaC-Tgmice, L/Lmice, and their respectiveWT littermates. Sectionswere stainedwithH&Eandevaluated for degenerative airwayepithelial cells
(arrows). Scale bars, 20m (upper panels) and 10m (lower panels). B, summary of airway epithelial necrosis as determined from the number of degenerative
epithelial cells per mm of the basement membrane. n 3–5mice for each group. *, p	 0.01 compared with WT. C–E, amiloride dose-response curves (C and
D) and summary of IC50 values (E) obtained from tracheal tissues of ENaC-Tgmice, L/Lmice, and respectiveWT littermates. n 6–12mice/group. *, p 0.01
compared with WTmice; †, p 0.001 compared with L/L mice. Error bars, S.E.
TABLE 1
Hill model dose-response fit parameters S.E. for ENaC channels in native tracheal epithelia of WT, L/L, and ENaC-Tgmice
Parameters were obtained from averaged amiloride dose-response data (see Fig. 6, C and D) fitted with single and two-component Hill equations (see “Experimental
Procedures”). Results are consistent with tracheal tissues from ENaC-Tg mice expressing a subpopulation of ENaC channels with low affinity toward amiloride. NS, not
significantly different.
Single component Hill
model IC50
Two-component Hill model Statistical comparison single versus
two-component modelaHigh affinity IC50 High affinity relativepopulation Ifrct Low affinity IC50
M M % M
WT 0.3
 0.0 0.3
 0.2 86
 105 0.9
 4.4 NS
L/L 0.6
 0.0 0.2
 0.2 22
 31 0.8
 0.3 NS
ENaC-Tg 1.8
 0.4 0.6
 0.1 64
 3.2 30.9
 0.7 p 0.025
aENaC-Tg Fcalc(3, 7) 59.3; WT Fcalc(3, 5) 0.2; Liddle Fcalc(3, 5) 2.5.
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Thus, these data suggest that the necrotic cells in ENaC-Tg
mouse airways may reflect excessive Na absorption via a pop-
ulation of unregulated  ENaC channels, whereas the absence
of necrotic cells suggests that the Liddle  ENaC channel is
sufficiently regulated in vivo to protect airway epithelia from
necrosis.
ENaC Regulation by Extracellular Proteases Is Abnormal in
Airways ofENaC-TgMice—Recent studies demonstrated that
proteolytic activation of  ENaC channels by extracellular
serine proteases plays an important role in regulating ENaC-
mediatedNaabsorptioninairwayepithelia.However,protease-
dependent activation is not required for  ENaC channels,
suggesting that the ENaC subunit is essential in this process
(47–49). To further test the hypothesis that ENaC-Tg mice
express abnormally regulated ENaC channels, we compared
ENaC regulation by both block of protease activation (aproti-
nin) and application of trypsin as a prototypic serine protease in
freshly excised WT and ENaC-Tg tracheal tissues. To maxi-
mize the effect of the block of protease activation of ENaC,
these experiments were performed in the presence of the serine
protease inhibitor aprotinin from the time immediately after
tracheal excision to a measure of steady state current 30 min
after mounting of the tissues in Ussing chambers. Amiloride-
sensitive Na transport was measured both under steady state
(aprotinin) conditions and after the addition of luminal trypsin.
Under steady state aprotinin conditions, the amiloride-sensi-
tive Isc was significantly (5.5-fold) increased in trachea from
ENaC-Tg compared with WT mice (Fig. 7). The subsequent
addition of trypsin to the luminal bath increased the amiloride-
sensitive Isc by a similar magnitude in WT and ENaC-Tg tra-
cheae (Isc 26.0
 5.6A/cm2, n 10 forWT;Isc 37.5

12.4 A/cm2, n  14 for ENaC-Tg; p  0.93), reducing the
ratio of amiloride-sensitive Isc in ENaC versus WT mice to
2.7-fold, typical forENaC-Tg andWT tissues in the absence
of aprotinin (16). Taken together, these data indicate that WT
and ENaC-Tg airway epithelia express a similar number of
apical membrane  ENaC channels that are largely inhibited
by aprotinin and reactivated by trypsin. The ENaC-Tg mice
express a population of  channels that are not regulated by
proteases, accounting for the proportionately reduced effects of
aprotinin and trypsin inENaC-Tgmice as comparedwithWT
mice.
DISCUSSION
Proper regulation of ASL volume, a function dependent on
coordinate regulation of ENaC-mediated Na absorption
and CFTR/CaCC-mediated Cl secretion, plays a critical
role in maintaining the normal mucociliary clearance com-
ponent of lung defense (50, 51). Therefore, defects in either
process (i.e. active Cl secretion or Na absorption) are pre-
dicted to produce ASL depletion, mucociliary dysfunction,
and lung disease. The aim of this study was to elucidate the
role of abnormal ENaC function and ASL volume regulation
in the in vivo pathogenesis of chronic airway disease. We
therefore studied a mouse model of a gain-of-function muta-
tion in ENaC (Liddle) reported to exhibit increased Na
absorption in renal and colonic epithelia (29–32). Our inves-
tigations led us to study both (i) why Liddle-mediated
increased Na transport was expressed in the tracheal but
not nasal epithelium and (ii) why, despite Ussing chamber
measured increases in Na transport in the Liddle trachea,
there was no associated lung disease.
First, we sought themechanisms to explain the apparent dis-
cordance of the Liddle Na transport phenotype in the two
respiratory regions (Fig. 1). The expression of all three ENaC
subunits (, , and ) is required to obtain maximal Na cur-
rents (1), and CFTR, Nedd4-2, and Sgk1 have been reported to
regulate apical membrane ENaC number and activity (10, 12,
23–26). We therefore hypothesized that absence of increased
Na absorption in nasal epithelia from Liddle compared with
WT mice was caused by reduced expression of - or ENaC
subunits or increased expression of ENaC regulators in nasal
epithelia from Liddle compared withWTmice. Comparison of
ENaC subunit expression levels between WT and Liddle mice
confirmed a 50% reduction in Liddle ENaC transcripts in
nasal epithelia, as previously described for kidney and colon
(29). However, no differences in expression levels of - or
ENaCor other ENaC regulators betweenWTand Liddle nasal
tissues were detected that could compensate for the Liddle
gain-of-function mutation (Fig. 2).
However, we noted that the level of CFTR expression inmice
was markedly higher in nasal compared with tracheal epithelia
in both WT and Liddle mice (Fig. 2). The importance of CFTR
in regulation of Na transport rates inmice has been suggested
previously by observations from CF mice. In CF mice, the
amiloride-sensitive Isc is raised in the nasal epithelia, but not
trachea, reflecting the likelihood that CFTR is expressed at lev-
els sufficient to regulate ENaC in the nasal cavity but that other
regulatory paths dominate in the lower airways, where CFTR
expression is very low (36, 37, 40). The role of CFTR in regula-
tion of Liddle ENaC in native airway tissues has not been stud-
ied, and co-expression studies in heterologous cells produced
conflicting results. Whereas one study suggested that CFTR
inhibits ENaC channels carrying Liddle mutations, including
stop mutations that produce truncations of the C termini of -
and ENaC (52), another study indicated that C termini of -
FIGURE 7. Regulation of ENaC by extracellular proteases is abnormal in
airwayepithelia fromENaC-Tgmice. Freshly excised tracheal tissues from
WT and ENaC-Tg mice were pretreated with luminal aprotinin, and amilo-
ride-sensitive Isc was measured either in the presence of aprotinin alone
(Aprotinin) or after the addition of luminal trypsin (Trypsin). n 9–14mice/
group. *,p 0.05; **,p 0.001 comparedwithmice of samegenotype; †,p
0.001 compared with WT mice; §, p 0.001 compared with ENaC-Tg mice.
Error bars, S.E.
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and ENaC are required for functional interaction between
CFTR and ENaC (53).
To genetically study the role of CFTR in regulation of Liddle
ENaC in native nasal versus tracheal epithelia, we crossed CF
micewith Liddlemice and observed a2-fold increase in PD in
CF-Liddle nasal as compared with CF nasal epithelia. The addi-
tivity in rates of Na transport observed in the CF-Liddle mice
compared with CF mice is consistent with the absence of
CFTR-mediated inhibition of ENaC in CFmice (10, 11, 13) and
gain of ENaC function in the Liddle mice (21, 54). In contrast,
the rates of Na transport in CF-Liddle and Liddle tracheas
were not different (Fig. 3), consistent with the relative absence
of CFTR expression, and hence CFTR regulatory function, in
either the Liddle or WT tracheas.
Thus, these genetic and functional studies demonstrate that
CFTR plays a critical role in the regulation of both WT and
Liddle ENaC in nasal epithelial cells that co-express ENaC and
CFTR. Similar to Liddle patients expressing the R556X muta-
tion, the C terminus of the ENaC subunit is truncated in
Liddle mice. Therefore, our studies suggest that the functional
interaction between CFTR and ENaC in native nasal tissues did
not rely on the presence of the ENaC C terminus. The gain of
Na transport function in the tracheas of Liddle mice is con-
sistent with data reporting Liddle mediated gain of Na trans-
port function in other epithelia in which CFTR is expressed at
low levels (e.g. the cortical collecting duct of the kidney or the
surface epithelium of the colon) (3, 55). Because in humans,
unlikemice, CFTR is co-expressed with ENaC at relatively high
levels in the surface epitheliumof both upper and lower airways
(56), our findings also may explain why patients with Liddle
syndrome do not develop CF-like lung disease (27, 28).
Second,we investigatedwhy increasedNa absorption in the
lower airways of Liddlemice did not cause CF-like lung disease.
In contrast to ENaC-Tg mice, Liddle mice exhibited an
absence of airwaymucus obstruction, goblet cell hyperplasia, or
inflammation (Fig. 4) (29, 33). We hypothesized that it may not
be an increase in the absolute rate of Na transport but rather
the lack of regulation ofNa transport required for normalASL
volume homeostasis that caused lung disease.
We tested the hypothesis that ENaC-Tg mice cannot regu-
late ENaC sufficiently for ASL volume homeostasis in vitro,
whereas Liddle mice can, by measuring ASL homeostasis in
primary tracheal cultures under thin film conditions in
response to a volume challenge.Normalmouse airway epithelia
exhibited ASL volume regulation similar to human epithelia,
with a key feature being inhibition of ENaC-mediated Na
transport as excess liquid is absorbed from the airway surface
(Fig. 5). The volume response of ENaC-Tg tracheal cultures
was strikingly similar to the response observed in human CF
airway cultures (i.e. initially accelerated absorption, failure to
slow absorption at low ASL volume, and steady state depletion
of ASL volume from epithelial surfaces) (Fig. 5) (39, 41). This
physiology is consistentwith a failure to regulate (inhibit) ENaC
at low ASL volumes.
In tracheal cultures from Liddle mice, consistent with
increased Na absorption observed in Ussing chamber
experiments under flooded conditions, the rate of absorp-
tion of the added liquid was accelerated. However, in con-
trast to ENaC-Tg epithelia, “normal” ASL volume homeo-
stasis was achieved in 6 h by Liddle tracheal cultures
following the removal of excess fluid, and ASL remained at a
steady state thereafter. With respect to the delay of normal
homeostaticASL regulation in Liddle comparedwithWTmice,
we speculate that Liddle (and WT) ENaC may be regulated by
soluble inhibitor(s) thatwere diluted after the volume challenge
and reconcentrated under thin film conditions. For example,
previous studies demonstrated that ENaC is activated by pro-
teolytic cleavage and blocked by protease inhibitors, suggesting
that an endogenous protease/antiprotease system plays an
important role in CFTR-independent regulation of ENaC on
airway surfaces (49, 57–59). Further, recent evidence suggested
that ENaC-activating proteases are membrane-anchored,
whereas protease inhibitors are soluble and can therefore act as
ASL sensors to inhibit ENaC activity under thin film conditions
(60). Because the Liddle mutation results in an increased num-
ber of active ENaC channels on the plasmamembrane, we spec-
ulate that (i) the early rapid phase of volume absorption
reflected the activity of a relatively (to WT) large number of
active ENaC channels on the membrane, and (ii) the return to
normal ASL homeostatic volumes reflected the gradual accu-
mulation of potentially higher concentrations of inhibitor
required to prevent activation of Liddle channels newly
inserted into the plasmamembrane. Thus, “normal” ASL regu-
lation under steady state conditions in Liddle epithelia suggests
the preservation of regulation (inhibition) of Liddle ENaC
under thin film conditions (Fig. 5).
A finding consistent with the key role of Na transport
(ENaC) inhibition in ASL regulation in ENaC-Tg versus
Liddlemice in vitrowas observed in vivo (i.e. necrotic cells were
detected in neonatal ENaC-Tg but not in Liddle mouse air-
ways). Like degenerin mutation-expressing neurons in C. el-
egans (42, 43), the presence of necrotic cells suggests unregu-
lated entry of Na into ENaC-Tg-expressing Clara cells,
leading to hydropic degeneration and necrosis. In a previous
study, we demonstrated that hydropic degeneration in neonatal
ENaC-Tg airways was reduced by preventive treatment with
amiloride (61). Interestingly, a link between Na channel dys-
regulation and cell death was also established in an animal
model for Duchenne muscular dystrophy. In mdx mice, the
absence of dystrophin causes dysregulation of the skeletal mus-
cle isoforms of the voltage-gated Na channel Nav1.4, produc-
ing intracellular Na overload and cell death, which were both
prevented by a specific Nav1.4 blocker (62). Taken together,
these data indicate that degeneration and cell death were a
direct consequence of dysregulated airway Na absorption in
ENaC-Tgmice. In contrast, necrotic cellswere not detected in
neonatal Liddle airway epithelia, suggesting that there was suf-
ficient regulation of Liddle ENaC channels in vivo to prevent
this event (Fig. 6).
Of note, hydropic degeneration was only observed in neona-
tal and not in adult ENaC-Tg airways (17). We speculate that
several factors may explain why Clara cells in adult ENaC-Tg
mice were protected from degeneration and cell death. Previ-
ous studies demonstrated that the activity of the Clara cell
secretory protein promoter peaks in newborn mice and wanes
thereafter (63). Consistentwith this finding, Clara cell secretory
ENaC and ASL Regulation
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protein-driven induction of ENaC transcripts and amiloride-
sensitive Isc was significantly greater in neonatal comparedwith
adult ENaC-Tg mice (supplemental Fig. 4). These results
suggest that lower levels of Na hyperabsorption may protect
Clara cells in adult ENaC-Tg airways from undergoing
hydropic degeneration. Additionally, Clara cells may be more
susceptible to Na influx in the neonatal period. For example,
in contrast to adult airways, Clara cells in neonatal airways store
large amounts of glycogen, which were depleted by Na
hyperabsorption in ENaC-Tg mice, suggesting that differ-
ences in energy metabolism in neonatal versus adult Clara cells
may contribute to susceptibility to cell death (17). Further, our
previous studies demonstrated that mucus plugging of central
airways is more severe in neonatal versus adult ENaC-Tg
mice. Therefore, airway hypoxia resulting from severe airway
mucus plugging may also contribute to cell death triggered by
Na hyperabsorption in neonatal ENaC-Tg airways (17).
Wehypothesized that the failure to regulateNa transport in
mice overexpressing the ENaC subunit (ENaC-Tg) reflected
the expression of a population of protease activation-indepen-
dent  ENaC channels in the luminal membrane of airway
epithelial cells. Indeed, we detected evidence for  ENaC
channels, as reflected in the relative insensitivity of Na trans-
port to amiloride inhibition and the detection of a subpopula-
tion of low affinity ENaC channels in native tracheal tissues
from ENaC-Tg mice (Fig. 6 and Table 1) (44). Further, our
data suggest that tracheal epithelia from ENaC-Tg mice
express a pool of  ENaC channels that remained constitu-
tively active during aprotinin treatment and were not activated
by subsequent trypsin addition (Fig. 7). Taken together with
previous studies demonstrating that (i) proteolytic cleavage by
extracellular proteases regulates ENaC activity by increasing
its Po and (ii) that the ENaC subunit plays an essential role in
this process (47–49), our results are consistent with the
hypothesis that airways from ENaC-Tg mice express 
ENaC channels that exhibit a basal Po of 1.0 (44) and are
insensitive to normal inhibitors of ENaC activity, including
endogenous protease inhibitors (59, 60) present in ASL in vitro
and in the vicinity of necrotic cells in vivo.
An important hypothesis generated by our comparisons
of Na transport in Ussing chambers versus thin film condi-
tions with the development of lung disease in Liddle versus
ENaC-Tgmice is that it is the regulation ofNa transport, not
the maximal rate of Na transport, that determines whether
airway surfaces are adequately hydrated for health. This
hypothesis is consistent with recent data that suggest that
bypassing the normal regulation of ENaC at low ASL volumes
with an unregulated “exogenous channel” (e.g. nystatin) can
produce a phenotype of ASL depletion and mucus adhesion to
airway surfaces (64). In the mouse experiments described here
and in human bronchial epithelial cells treated with mucosal
nystatin (64), the persistence of the capacity to secrete Cl is
not sufficient to protect the hydration status of the airway sur-
face. This result probably reflects the inability of airway epithe-
lia to generate driving forces sufficient to secrete Cl in the
absence of ENaC inhibition (65).
In summary, our study demonstrated that CFTR inhibits the
increase in Na absorption caused by Liddle ENaC when the
two proteins are endogenously co-expressed in nasal epithelia.
Because humans also co-express both CFTR and ENaC in the
lower airways, we suggest that this mechanism protects Liddle
patients from CF-like lung disease (28, 56). Importantly, our
studies inmice indicate that, under physiological thin film con-
ditions, non-CFTR-mediated regulatory factors inhibit the
raisedNa absorption intrinsic to the Liddlemutation in ENaC
and thus mediate normal ASL homeostasis and protect Liddle
mice from lower airway disease. The importance of ASL vol-
ume regulation was buttressed by the observation that trans-
genic overexpression of wild-type ENaC escaped the ENaC
regulation required for ASL homeostasis and produced airway
dehydration and CF-like lung disease. Further elucidation of
the pathways that regulate ENaC under thin film conditions
may produce novel therapeutic targets for pulmonary dis-
eases caused by increased ENaC-mediated Na absorption,
such as CF.
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